quality adjusted life year

quality adjusted life year

A parameter derived from a modification of standard life-table procedures, which is designed to take account of the quality of life as well as the duration of survival with a particular disease—e.g., cancer, diabetes, multiple sclerosis. QALY can also be used in assessing the outcome of healthcare procedures or services.
References in periodicals archive ?
The analysis was derived from estimates of cost and quality adjusted life year (QALY) measures, which were based on key parameters, including length of hospital stay and number of hospital admissions.
Additionally, the study found the incremental cost-effectiveness ratio was just over $4,000 for an increase of one Quality Adjusted Life Year and just over $20,000 for preventing one stroke.
The Quality Adjusted Life Year (QALY) measurement survey will hopefully show an improvement in quality of life - a recognised and important measure in NHS decisionmaking.
There is unfortunately the same basic fallacy that the calculus of medical value is based on the Quality Adjusted Life Year (QALY).
But a preliminary appraisal by the New Medicines Group issued to AWMSG says the case for cost-effectiveness for the drug "has not been proven" and estimates the cost to be more than PS500,000 per quality adjusted life year - a measurement which looks at both the quality and the quantity of life added by a drug.
If a study is conducted as a cost-utility analysis, quality adjusted life year (QALY) is a necessary measurement.
Ismael Ortega-Sanchez, also with the NCIRD, showed that giving just one dose of MCV4 to all 11-year-olds was the least cost-effective of several options the ACIP considered, at $281,000 per quality adjusted life year (QALY).
They have offered a patient access scheme to reduce the costs to pounds 36,000 per quality adjusted life year - but this is still above the pounds 30,000 NICE threshold.
Researchers used the Quality Adjusted Life Year (QALY) scale to measure benefit to patients in comparison to the direct and indirect costs of the surgical procedures over a two-year period after surgery.
Even if the prevalence were as low as 5/10,000, the cost per quality adjusted life year would still be under $50,000.
Set against the Quality Adjusted Life Year scale, which measures 'life gains', it works out about pounds 19,000 but compared to the cost of prescribing antibiotics for meningitis, it's still an expensive option.
The study found that using Corus CAD as a means of identifying patients who need no referral versus those who need referral to myocardial perfusion imaging (MPI) or invasive coronary angiography (ICA) is cost effective at $72,202 per quality adjusted life year (QALY) gained in a patient cohort closely resembling the commercial intended population for Corus CAD.

Full browser ?